Bionano Genomics Statistics
Total Valuation
BNGO has a market cap or net worth of $5.64 million. The enterprise value is $16.14 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BNGO has 1.70 million shares outstanding. The number of shares has increased by 94.65% in one year.
| Current Share Class | 1.70M |
| Shares Outstanding | 1.70M |
| Shares Change (YoY) | +94.65% |
| Shares Change (QoQ) | +27.06% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 1.64% |
| Float | 1.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| Forward PS | 0.21 |
| PB Ratio | 0.10 |
| P/TBV Ratio | 0.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.43 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.21 |
Financial Efficiency
Return on equity (ROE) is -161.77% and return on invested capital (ROIC) is -65.04%.
| Return on Equity (ROE) | -161.77% |
| Return on Assets (ROA) | -48.42% |
| Return on Invested Capital (ROIC) | -65.04% |
| Return on Capital Employed (ROCE) | -191.70% |
| Revenue Per Employee | $96,901 |
| Profits Per Employee | -$394,718 |
| Employee Count | 344 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 1.67 |
Taxes
| Income Tax | -4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.78% in the last 52 weeks. The beta is 2.25, so BNGO's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | -94.78% |
| 50-Day Moving Average | 7.77 |
| 200-Day Moving Average | 23.28 |
| Relative Strength Index (RSI) | 23.11 |
| Average Volume (20 Days) | 120,215 |
Short Selling Information
The latest short interest is 471,050, so 27.71% of the outstanding shares have been sold short.
| Short Interest | 471,050 |
| Short Previous Month | 443,900 |
| Short % of Shares Out | 27.71% |
| Short % of Float | 31.02% |
| Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, BNGO had revenue of $33.33 million and -$135.78 million in losses. Loss per share was -$132.48.
| Revenue | 33.33M |
| Gross Profit | -599,000 |
| Operating Income | -104.31M |
| Pretax Income | -204.09M |
| Net Income | -135.78M |
| EBITDA | -89.09M |
| EBIT | -104.31M |
| Loss Per Share | -$132.48 |
Full Income StatementBalance Sheet
The company has $11.95 million in cash and $22.45 million in debt, giving a net cash position of -$10.50 million or -$6.18 per share.
| Cash & Cash Equivalents | 11.95M |
| Total Debt | 22.45M |
| Net Cash | -10.50M |
| Net Cash Per Share | -$6.18 |
| Equity (Book Value) | 48.87M |
| Book Value Per Share | 33.14 |
| Working Capital | 14.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$92.20 million and capital expenditures -$848,000, giving a free cash flow of -$93.05 million.
| Operating Cash Flow | -92.20M |
| Capital Expenditures | -848,000 |
| Free Cash Flow | -93.05M |
| FCF Per Share | -$54.74 |
Full Cash Flow StatementMargins
| Gross Margin | -1.80% |
| Operating Margin | -312.92% |
| Pretax Margin | -407.35% |
| Profit Margin | n/a |
| EBITDA Margin | -267.26% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BNGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -94.65% |
| Shareholder Yield | -94.65% |
| Earnings Yield | -2,405.95% |
| FCF Yield | -1,648.67% |
Analyst Forecast
The average price target for BNGO is $60.00, which is 1,707.23% higher than the current price. The consensus rating is "Hold".
| Price Target | $60.00 |
| Price Target Difference | 1,707.23% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 32.21% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.0166667:1.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0166667:1 |
Scores
BNGO has an Altman Z-Score of -13.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.29 |
| Piotroski F-Score | 2 |